FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315568047> ?p ?o ?g. }

• W4315568047 abstract "Recurrence and metastasis are the main causes of breast cancer (BRCA)-related death and remain a challenge for treatment. In-depth research on the molecular mechanisms underlying BRCA progression has been an important basis for developing precise biomarkers and therapy targets for early prediction and treatment of progressed BRCA. Herein, we identified FERM domain-containing protein 3 (FRMD3) as a novel potent BRCA tumor suppressor which is significantly downregulated in BRCA clinical tissue and cell lines, and low FRMD3 expression has been closely associated with progressive BRCA and shortened survival time in BRCA patients. Overexpression and knockdown experiments have revealed that FRMD3 significantly inhibits BRCA cell proliferation, migration, and invasion in vitro and suppresses BRCA xenograft growth and metastasis in vivo as well. Mechanistically, FRMD3 can interact with vimentin and ubiquitin protein ligase E3A(UBE3A) to induce the polyubiquitin-mediated proteasomal degradation of vimentin, which subsequently downregulates focal adhesion complex proteins and pro-cancerous signaling activation, thereby resulting in cytoskeletal rearrangement and defects in cell morphology and focal adhesion. Further evidence has confirmed that FRMD3-mediated vimentin degradation accounts for the anti-proliferation and anti-metastasis effects of FRMD3 on BRCA. Moreover, the N-terminal ubiquitin-like domain of FRMD3 has been identified as responsible for FRMD3-vimentin interaction through binding the head domain of vimentin and the truncated FRMD3 with the deletion of ubiquitin-like domain almost completely loses the anti-BRCA effects. Taken together, our study indicates significant potential for the use of FRMD3 as a novel prognosis biomarker and a therapeutic target of BRCA and provides an additional mechanism underlying the degradation of vimentin and BRCA progression." @default.
• W4315568047 created "2023-01-11" @default.
• W4315568047 creator A5008609733 @default.
• W4315568047 creator A5016888447 @default.
• W4315568047 creator A5020070866 @default.
• W4315568047 creator A5020147975 @default.
• W4315568047 creator A5023307885 @default.
• W4315568047 creator A5025167286 @default.
• W4315568047 creator A5036381691 @default.
• W4315568047 creator A5037269917 @default.
• W4315568047 creator A5041554294 @default.
• W4315568047 creator A5046849377 @default.
• W4315568047 creator A5049798193 @default.
• W4315568047 creator A5055401764 @default.
• W4315568047 creator A5055910593 @default.
• W4315568047 creator A5076463914 @default.
• W4315568047 creator A5087757321 @default.
• W4315568047 date "2023-01-11" @default.
• W4315568047 modified "2023-10-16" @default.
• W4315568047 title "FRMD3 inhibits the growth and metastasis of breast cancer through the ubiquitination-mediated degradation of vimentin and subsequent impairment of focal adhesion" @default.
• W4315568047 cites W1842994045 @default.
• W4315568047 cites W1976215621 @default.
• W4315568047 cites W1986413607 @default.
• W4315568047 cites W1995097523 @default.
• W4315568047 cites W2002074788 @default.
• W4315568047 cites W2045095436 @default.
• W4315568047 cites W2074070818 @default.
• W4315568047 cites W2119655833 @default.
• W4315568047 cites W2162262059 @default.
• W4315568047 cites W2172217169 @default.
• W4315568047 cites W2208157734 @default.
• W4315568047 cites W2264559502 @default.
• W4315568047 cites W2472899497 @default.
• W4315568047 cites W2733398634 @default.
• W4315568047 cites W2736730167 @default.
• W4315568047 cites W2744991274 @default.
• W4315568047 cites W2755452354 @default.
• W4315568047 cites W2765387868 @default.
• W4315568047 cites W2790082524 @default.
• W4315568047 cites W2792552001 @default.
• W4315568047 cites W2805117735 @default.
• W4315568047 cites W2838320657 @default.
• W4315568047 cites W2867022353 @default.
• W4315568047 cites W2901242178 @default.
• W4315568047 cites W2901606464 @default.
• W4315568047 cites W2921665934 @default.
• W4315568047 cites W2969845879 @default.
• W4315568047 cites W2975436058 @default.
• W4315568047 cites W2977466359 @default.
• W4315568047 cites W2995707458 @default.
• W4315568047 cites W3000307676 @default.
• W4315568047 cites W3022578407 @default.
• W4315568047 cites W3043287600 @default.
• W4315568047 cites W3091805122 @default.
• W4315568047 cites W3091939624 @default.
• W4315568047 cites W3108206876 @default.
• W4315568047 cites W3112550022 @default.
• W4315568047 cites W3112738131 @default.
• W4315568047 cites W3126805840 @default.
• W4315568047 cites W3127399859 @default.
• W4315568047 cites W3135002571 @default.
• W4315568047 cites W3156309512 @default.
• W4315568047 cites W3159674964 @default.
• W4315568047 cites W3164605289 @default.
• W4315568047 cites W3167771371 @default.
• W4315568047 cites W3180008318 @default.
• W4315568047 cites W3190184148 @default.
• W4315568047 cites W3203759325 @default.
• W4315568047 cites W3211690450 @default.
• W4315568047 cites W4200026187 @default.
• W4315568047 cites W4205724345 @default.
• W4315568047 cites W4211005384 @default.
• W4315568047 doi "https://doi.org/10.1038/s41419-023-05552-2" @default.
• W4315568047 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36631457" @default.
• W4315568047 hasPublicationYear "2023" @default.
• W4315568047 type Work @default.
• W4315568047 citedByCount "1" @default.
• W4315568047 countsByYear W43155680472023 @default.
• W4315568047 crossrefType "journal-article" @default.
• W4315568047 hasAuthorship W4315568047A5008609733 @default.
• W4315568047 hasAuthorship W4315568047A5016888447 @default.
• W4315568047 hasAuthorship W4315568047A5020070866 @default.
• W4315568047 hasAuthorship W4315568047A5020147975 @default.
• W4315568047 hasAuthorship W4315568047A5023307885 @default.
• W4315568047 hasAuthorship W4315568047A5025167286 @default.
• W4315568047 hasAuthorship W4315568047A5036381691 @default.
• W4315568047 hasAuthorship W4315568047A5037269917 @default.
• W4315568047 hasAuthorship W4315568047A5041554294 @default.
• W4315568047 hasAuthorship W4315568047A5046849377 @default.
• W4315568047 hasAuthorship W4315568047A5049798193 @default.
• W4315568047 hasAuthorship W4315568047A5055401764 @default.
• W4315568047 hasAuthorship W4315568047A5055910593 @default.
• W4315568047 hasAuthorship W4315568047A5076463914 @default.
• W4315568047 hasAuthorship W4315568047A5087757321 @default.
• W4315568047 hasBestOaLocation W43155680471 @default.
• W4315568047 hasConcept C104317684 @default.
• W4315568047 hasConcept C121608353 @default.
• W4315568047 hasConcept C134459356 @default.
• W4315568047 hasConcept C147447768 @default.
• W4315568047 hasConcept C151166631 @default.

• next